Catheters are medical tubes inserted into a body cavity, duct or vessel to allow for drainage of fluids, administration of fluids or gases, or access by surgical or diagnostic instruments. Antimicrobial catheters are coated or impregnated with antimicrobial agents such as antibiotics and antiseptics to reduce the risk of catheter-associated urinary tract infections (CAUTIs). Common types of antimicrobial catheters include foley catheters, central venous catheters, peripheral venous catheters and cardiac catheters.
The global Antimicrobial Catheter Market is estimated to be valued at US$ 12591.03 Mn in 2023 and is expected to exhibit a CAGR of 11 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The global market is driven by the rising prevalence of hospital-acquired infections such as UTIs and BSIs. CAUTIs account for the majority of all hospital-acquired infections, impacting around 15% of all hospital patients annually. This has increased the demand for innovative catheter technologies that prevent the entry and growth of microbes.
Market Dynamics
The antimicrobial catheter market is poised for rapid growth due to the rising prevalence of hospital-acquired infections, which is one of the key opportunities highlighted in the heading. Hospital-acquired infections not only increase patient morbidity and mortality but also pose a significant economic burden on healthcare systems worldwide. It is estimated that HAIs add over $28 billion to US healthcare costs annually. The growing focus on prevention of HAIs is encouraging the adoption of antimicrobial catheters which have been shown to reduce catheter-associated UTIs and BSIs by 20-70% compared to standard catheters. Another major driver is the increasing cases of antimicrobial resistance. The surge in multidrug-resistant organisms has heightened the need for advanced catheter technologies that can help curb the emergence and spread of such infections. The market will also gain from ongoing innovation led by leading players to develop more effective infection control solutions.
Segment Analysis
The global antimicrobial catheter market is dominated by the urinary catheter sub segment which holds around 60% market share. Urinary catheters are extensively used in hospitals and long term care facilities for management of urinary incontinence and retention. These catheters help drain urine from bladder and prevent infections of urinary tract. The high use of urinary catheters in healthcare settings for management of various urological conditions has made it the dominating sub segment in the antimicrobial catheter market.
PEST Analysis
Political: Governments across major countries are focusing more on improving healthcare infrastructure and reducing hospital acquired infections. This is positively impacting the demand for antimicrobial medical devices like catheters.
Economic: Rising geriatric population globally prone to chronic illnesses is driving the healthcare spending. Growing per capita healthcare expenditure is favoring the adoption of premium products like antimicrobial catheters to reduce infection risk.
Social: Increasing awareness about infection control and prevention among patients as well as healthcare providers is augmenting the preference for antimicrobial coated or impregnated devices over conventional ones.
Technological: Leading players are investing in R&D to develop newer and advanced antimicrobial coating technologies that can deliver long lasting protection against wide range of pathogens and drug resistant microbes.
Key Takeaways
The global antimicrobial catheter market share is expected to witness high growth at a CAGR of 11% during the forecast period of 2023 to 2030.
Regional analysis: North America dominates currently with more than 35% value share owing to new product launches and availability of advanced healthcare infrastructure in countries like US and Canada. However, Asia Pacific is anticipated to emerge as the fastest growing regional market attributed to rising medical tourism, growing demand for superior quality healthcare and expanding healthcare spending in countries like China, India and Indonesia.
Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
